Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 27, 1997 - Issue 11
21
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Comutagenesis-III. In vitro metabolism of 2-amino3-methylpyridine : the effect of various potential inhibitors, activators and inducers

&
Pages 1103-1111 | Published online: 22 Sep 2008

References

  • ALTUNTAS, T. G. and GORROD, J. W.,1996, Effect of various potentialinhibitors, activators and inducers on the N-oxidation of isomeric aromatic diazines in vitro using rabbit liver microsomal preparations. Xenobiotica, 26, 9–15.
  • ALTUNTAS, T. G. and GORROD, J. W. 1997a, Comutagenesis-II: Some factors influencing in vitro metabolism of 2-amino-2-methylpyridine.Drug Metabolism and Drug Interactions 13, 271–283.
  • ALTUNTAS, T. G. and GORROD, J. W., 1997b, Comutagenesis-IV: In vitro metabolism of the comutagen 2-amino-3-methylpyridine: species differences and metabolic interaction with norharman. Anticancer Research, in press.
  • ALTUNTAS, T. G., MANSON, D., ZHAO, K. and GORROD, J. W., 1997, Comutagenesis-I: The in vitro metabolism of 2-amino-3 -methylpyridine. Anticancer Research 17, 3485–3492.
  • ANDERS M. W. and MANNERING, G. J.,1996, Inhibitionof drug metabolism I. Kineticsof the inhibition of N-demethylation of ethylmorphine by 2-diethylaminoethy1-2,2-diphenylvalerat HCL (SKF 525-A) and related compounds. Molecular Pharmacology, 2, 319–327.
  • CHEN, T. S. and DuBois, K. P., 1973, Studies on the enzyme inducing effect of polychlorinated biphenyls. Toxicology and Applied Pharmacology 26, 504–512.
  • CLEMENT, B. and KUNZE, T., 1992, The reduction of 6-N-hydroxylaminopurine to adenine by xanthine oxidase. Biochemical Pharmacology, 44, 1501–1509.
  • GONZALEZ, F. J., 1996, The CYP2D subfamily. In Cytochrome P450: Metabolic and Toxicological Aspects, edited by C. Ioannides (Boca Raton: CRC Press), pp. 183–210.
  • GORROD, J. W., 1979, Toxic products formed during the metabolism of drugs and foreign compounds. In Drug Toxicity, edited by J. W. Gorrod (London: Taylor & Francis), pp. 1–24.
  • GORROD, J. W. and DAMANI, L. A., 1979, The effect of various potential inhibitors, activators and inducers on the N-oxidation of 3-substituted pyridines in vitro. Xenobiotka, 9, 219–226.
  • GORROD, J. W. and ILEs, N. C., 1991, The probable role of N-oxidation in a mechanism for the comutagenicityof norharman. Progress in Pharmacology and Clinical Pharmacology, 8, 327–333.
  • GORROD, J. W. and PATTERSON, L. H., 1983, The metabolism of 4-substituted N-ethyl-N-methy-lanilines. III. Effect of various potential inhibitors, activators and inducers on a-C- and N-oxidation. Xenobiotith, 13, 521–529.
  • GORROD, J. W., TEMPLE, D. J. and BECKETT, A. H., 1975, The metabolism of N-ethyl-N-methylaniline by rabbit liver microsomes: the measurement of metabolites by gas-liquid chromatography. Xenobiotka, 5, 453–463.
  • IOANNIDES, C., (ed.), 1996, Cytochromes P450: Metabolic and Toxicological Aspects (Boca Raton: CRC Press).
  • MAUREL, P., 1996, The CYP3 family. In Cytochrome P450: Metabolic and Toxkologkal Aspects, edited by C. Ioannides (Boca Raton: CRC Press), pp. 241–270.
  • NAGAO, M., YAHAGI, T., KAWACHI, T., SUGEVIURA T., KASUGE, T., Tsuji, K., WAKABAYASHI, K., MUUSAKI, S. and MATSUMATO, T., 1977, Comutagenic action of norharman and harman. Proceedings of the Japan Academy, 53, 95–98.
  • OKEY, A. B., 1990, Enzyme induction in the cytochrome P450 system. Pharmacology and Therapeutics, 45, 241–298.
  • OMURA, T. and SATO, R., 1964, The carbon monooxide-bindingpigmentof liver microsomes I. Evidence for its hemoprotein nature. journal of Biological Chemistry, 239, 2370–2378.
  • POINDDCTER, E. H. and Carpenter, R. D., 1962, The isolation of harman and norharman from tabacco and cigarette smoke. Phytochemistry, 1, 215–221.
  • POULSEN, L. L. and ZIEGLER, D. M., 1979, The liver microsomal FAD-containing monooxygenase. Journal of Biological Chemistry, 254, 6449–6455.
  • RONIS, M. J. J., LINDROS, K. O. and INGELMAN -SUNDBERG M., 1996, The CYP2E subfamily. In Cytochrome P450 : Metabolic cmd Toxicological Aspects, edited by C. Ioannides(Boca Raton: CRC Press), pp. 211–239.
  • RICHARDSON, T. H. and JOHNSON, E. F.,1996, The CYP2C subfamily. In Cytochrome P450: Metabolic and Toxicological Aspects, edited by C. Ioannides (Boca Raton: CRC Press), pp. 161–181.
  • SCHENKMAN J. B. and CINTI, D. L., 1978, Preparation of microsomes with calcium. Methods in Enzymology, 52, 83–89.
  • SKELLERN, G. G. and STEER, S. T., 1981, The metabolism of [2-'4C]methimazolein the rat. Xenobiotka, 11, 627–634.
  • SMITH, M. R. and GORROD, J. W., 1978, The microsoma1N-oxidationof some primaryaromatic amines. In Biological Oxidation of Nitrogen, edited by J. W. Gorrod (Amsterdam: Elsevier Biomedical), pp. 65–70.
  • SUGIMURA, T., NAGAO, M. and WAKABAYASHI, K., 1982, Metabolic aspects of the comutagenicaction of norharrnan. Advances in Experimental Medicine and Biology, 136, 1011–1025.
  • TORIGOE, Y., YAMAMOTO, T., KOSUGE, T. and ZENDA, H., 1973, Studies on the active principles of tar. III. Antihistaminic and antifungal constituents in dry distillation tar of non-fat soyabean. Yakugaku Zasshi, 93, 39–43.
  • TSUJI, K., ZENDA H. and KOSUGE, T., 1973, Studies on active principles of tar. II. Antifungal constituents in charred egg yolk or in egg tar. Yakugaku Zasshi, 93, 33–38.
  • ZIEGLER, D. M. and MITCHELL, C. H., 1972, Microsomal oxidase. IV. Properties of a mixed-function amine oxidase isolated from pig liver microsomes. Archives of Biochemistry and Biophysics, 150, 116–125.
  • ZIEGLER, D. M., MITCHELL, C. H. and JoLLow, D., 1969, The properties of purified hepatic microsomal mixed function amine oxidase. In Mkrosomes and Drug Oxidations, edited by J. R. Gillette, A. H. Conney, G. I. Cosmides, R. W. Estabrook, J. R., Fouts and G. J. Mannering (New York: Academic), pp. 173–188.
  • ZIEGLER, D. M., POULSEN, L. L. and McKEE, E. M., 1971, Interaction of primary amines with a mixed function amine oxidase isolated from pig liver microsomes. Xenobiotka, 1, 523–531.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.